ENGOT-ov56-NSGO-CTU/DOVACC
Trial Description:
A Randomized Clinical Trial Investigating Olaparib, Durvalumab (MEDI4736) and UV1 as Maintenance Therapy in BRCAwt Patients with Recurrent Ovarian Cancer
Lead Cooperative Group:
Trial Number:
Disease Site:
Ovarian
Trial Status:
Recruiting
Contact person:
mraza